Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloid-derived Suppressor Cells in Colorectal Cancer: Influence on Postoperative Complications and Neoadjuvant Treatment

NCT04943419 is registered in ClinicalTrials.gov with Jagiellonian University as lead sponsor.

NCT NCT04943419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloid-derived Suppressor Cells in Colorectal Cancer: Influence on Postoperative Complications and Neoadjuvant Treatment
Lead sponsor
Jagiellonian University
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
June 21, 2021
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, complication,postoperative, radiotherapy, suppression